We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Sphere Medical

Sphere Medical develops medical monitoring and diagnostic equipment, including the CE-marked Proxima platform for mea... read more Featured Products: More products

Download Mobile App




CE-Marked Blood Analyzer Interfaces with Popular Data Management System

By LabMedica International staff writers
Posted on 12 Sep 2016
Unique point-of-care (POC) connectivity to a widely used information transfer and management system is now available for a novel in-line arterial blood analyzer that supports rapid and frequent measurement of blood gases, electrolytes, and metabolites to monitor critical care patients without leaving bedside. More...


The CE-marked Proxima blood analysis device from Sphere Medical (Cambridgeshire UK) can now be connected into the family of laboratory information system interfaces and data management solutions from Conworx Technology (Berlin, Germany). This is a significant development since it provides near real-time feedback and ensures seamless transfer of test results from Proxim directly into laboratory information management systems (LIMSs) and electronic patient records – a key requirement for the successful implementation of POC testing.

Proxima supports patient critical care, including in the ICU and OR. The device sensor is a miniaturized blood gas analyzer integrated directly into the patient’s arterial line so that analyzed blood is returned to the patient. A dedicated bedside monitor with touch screen interface also provides simple, clear user-guiding routines.

With the new software drivers, users will be able to directly import diagnostics data from Proxima at patient bedside into Conworx’s POCcelerator, UniPOC middleware data management systems. In addition, the new interface will allow direct connectivity into CliniSys, a LIMS, through the CliniSys PoCT Solutions interface.

Both Conworx and CliniSys software solutions are being used in many hospitals globally, which would help ensure that data transfer from Proxima can be easily implemented, and its use and performance readily monitored remotely. Conworx’s middleware solutions provide connectivity, management, and integration for over 150 different POCT device types, as well as all relevant information and patient record systems. The Conworx base currently includes 1800 hospitals in 25 countries, and CliniSys software systems are used in over 2500 laboratories in 35 countries.

Sphere Medical CEO, Wolfgang Rencken, said: “This presents a huge step forward into integrating data from Proxima into laboratory information systems and electronic patient records. Partnering with Conworx allows our customers to use one middleware solution for all of their POC connectivity needs and greatly simplifies the implementation of Proxima within the hospital.”

Conworx CEO, Roman Rosenkranz, said: “We are delighted to be able to offer the first interface to an ex-vivo analyzer, which provides a seamless connection from the patient right through to the laboratory information system.”

Related Links:
Sphere Medical
Conworx Technology

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Nucleic Acid Purification Instrument
QIAsymphony Connect
New
Gold Member
Serum Indices Control
Acusera Serum Indices Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: WashU Medicine researchers found that dozens of blood proteins shift during Alzheimer’s treatment and may help monitor the effects of the medication. (Image Credit: Matt Miller/WashU Medicine)

Blood Biomarker Patterns Could Support Monitoring of Anti-Amyloid Treatment

Patients with early-stage Alzheimer’s disease may receive anti-amyloid therapy to clear amyloid protein deposits from the brain. These treatments can slow disease progression, but they do not cure the... Read more

Molecular Diagnostics

view channel
Image: University of Florida scientists Hugh Fan, Ph.D., and John Lednicky, Ph.D., led the development of a cost-effective, accurate handheld device capable of simultaneously testing for seven different mosquito-borne viruses. (Image Credit: UF Health photo by Hannah Clark)

Portable Test Differentiates Seven Mosquito-Borne Viruses at Point of Care

Mosquito-borne viral illnesses can present with overlapping symptoms such as fever, joint pain, fatigue, and rash, making them difficult to distinguish without laboratory testing. In these settings, clinicians... Read more

Immunology

view channel
Image: Aptiva utilizes particle-based multi-analyte technology (PMAT) (Photo courtesy of Werfen)

Werfen Expands Automated APS Testing with FDA-Cleared and CE-Marked IgA Reagent

Antiphospholipid syndrome (APS) is an autoimmune disorder associated with thrombosis and pregnancy complications, but its symptoms can overlap with those of other conditions, complicating diagnosis.... Read more

Microbiology

view channel
Image: Each PhAST instrument supports random-access processing of up to four samples simultaneously, delivering a throughput of up to 12 samples per eight-hour shift. (Photo courtesy of PhAST)

FDA Clears Rapid Phenotypic Antimicrobial Susceptibility System for Positive Blood Cultures

Bloodstream infections require prompt treatment, but antimicrobial susceptibility results often lag behind a positive blood culture. Conventional testing can take another 24 to 48 hours after a culture... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.